Session Details
Symposium 14
Amyloid β Targeting Disease-Modifying Therapies for Alzheimer's Disease: Clinical Implementation and Future Outlook
Sat. Aug 30, 2025 4:30 PM - 5:30 PM JST
Sat. Aug 30, 2025 7:30 AM - 8:30 AM UTC
Sat. Aug 30, 2025 7:30 AM - 8:30 AM UTC
Room 2(Arcrea HIMEJI, 2F Medium Hall)
Chair: Shingo Kakeda( Hirosaki University )
[SY14-1]Anti-Amyloid-Beta Antibody Therapy as a Disease-Modifying Treatment: Current Status and Future Directions
○Akitoshi Takeda (Department of Neurology, Osaka Metropolitan University)
[SY14-2]MRI in the Clinical Deployment of Anti-Amyloid β Antibody Therapies: Roles, Challenges, and Future Directions
○Aya Midori Tokumaru (Department of Diagnostic Radiology, Tokyo Metropolitan Medical Institute for Geriatrics and Gerontology)
[SY14-3]Biomarkers to Guide the Present and Future of Anti-Amyloid Immunotherapies
○Makoto Higuchi1,2 (1.Advanced Neuroimaging Center, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, 2.大阪公立大学大学院医学研究科 病因診断科学)